Nanoviricides Stock Analysis
| NNVC Stock | USD 1.68 0.04 2.44% |
NanoViricides is undervalued with Real Value of 2.51 and Target Price of 5.25. The main objective of NanoViricides stock analysis is to determine its intrinsic value, which is an estimate of what NanoViricides is worth, separate from its market price. There are two main types of NanoViricides' stock analysis: fundamental analysis and technical analysis.
The NanoViricides stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and NanoViricides' ongoing operational relationships across important fundamental and technical indicators.
NanoViricides | Build AI portfolio with NanoViricides Stock |
NanoViricides Stock Analysis Notes
The book value of the company was now reported as 0.55. The company recorded a loss per share of 0.69. NanoViricides last dividend was issued on the 24th of September 2019. The entity had 1:20 split on the 24th of September 2019. NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company was founded in 2005 and is based in Shelton, Connecticut. Nanoviricides operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 17 people. To find out more about NanoViricides contact the company at 203 937 6137 or learn more at https://www.nanoviricides.com.NanoViricides Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. NanoViricides' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding NanoViricides or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| NanoViricides is way too risky over 90 days horizon | |
| NanoViricides may become a speculative penny stock | |
| NanoViricides appears to be risky and price may revert if volatility continues | |
| NanoViricides has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (8.29 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NanoViricides currently holds about 14.07 M in cash with (6.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.21. | |
| NanoViricides has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: NanoViricides Advances MPox Treatment Amid WHO Alert NNVC Stock News |
NanoViricides Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to NanoViricides previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
NanoViricides Largest EPS Surprises
Earnings surprises can significantly impact NanoViricides' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2019-08-22 | 2019-06-30 | -0.04 | -0.03 | 0.01 | 25 | ||
2023-10-13 | 2023-09-30 | -0.17 | -0.15 | 0.02 | 11 | ||
2023-05-15 | 2023-03-31 | -0.17 | -0.1463 | 0.0237 | 13 |
NanoViricides Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 27 M.NanoViricides Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.60) | (0.63) | |
| Return On Capital Employed | (0.67) | (0.70) | |
| Return On Assets | (0.58) | (0.61) | |
| Return On Equity | (0.65) | (0.68) |
Management Efficiency
NanoViricides has return on total asset (ROA) of (0.5738) % which means that it has lost $0.5738 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9984) %, meaning that it created substantial loss on money invested by shareholders. NanoViricides' management efficiency ratios could be used to measure how well NanoViricides manages its routine affairs as well as how well it operates its assets and liabilities. As of July 20, 2025, Return On Tangible Assets is expected to decline to -0.63. In addition to that, Return On Capital Employed is expected to decline to -0.7. At present, NanoViricides' Other Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 22 M, whereas Non Current Assets Total are forecasted to decline to about 6.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.87 | 0.83 | |
| Tangible Book Value Per Share | 0.84 | 0.80 | |
| Enterprise Value Over EBITDA | (1.99) | (2.09) | |
| Price Book Value Ratio | 1.72 | 2.98 | |
| Enterprise Value Multiple | (1.99) | (2.09) | |
| Price Fair Value | 1.72 | 2.98 | |
| Enterprise Value | 6 M | 5.7 M |
The leadership approach at NanoViricides' fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Technical Drivers
As of the 20th of July, NanoViricides secures the Risk Adjusted Performance of 0.1185, mean deviation of 4.08, and Downside Deviation of 4.72. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NanoViricides, as well as the relationship between them.NanoViricides Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Simple Moving Average indicator is calculated by adding the closing price of NanoViricides for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out NanoViricides short-term fluctuations and highlight longer-term trends or cycles.
NanoViricides Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NanoViricides insiders, such as employees or executives, is commonly permitted as long as it does not rely on NanoViricides' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NanoViricides insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
NanoViricides Outstanding Bonds
NanoViricides issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NanoViricides uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NanoViricides bonds can be classified according to their maturity, which is the date when NanoViricides has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
NanoViricides Predictive Daily Indicators
NanoViricides intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NanoViricides stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NanoViricides Forecast Models
NanoViricides' time-series forecasting models are one of many NanoViricides' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NanoViricides' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About NanoViricides Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NanoViricides prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NanoViricides shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NanoViricides. By using and applying NanoViricides Stock analysis, traders can create a robust methodology for identifying NanoViricides entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Current NanoViricides Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. NanoViricides analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. NanoViricides analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 5.25 | Strong Buy | 1 | Odds |
Most NanoViricides analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand NanoViricides stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of NanoViricides, talking to its executives and customers, or listening to NanoViricides conference calls.
NanoViricides Stock Analysis Indicators
NanoViricides stock analysis indicators help investors evaluate how NanoViricides stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading NanoViricides shares will generate the highest return on investment. By understating and applying NanoViricides stock analysis, traders can identify NanoViricides position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 8.1 M | |
| Common Stock Shares Outstanding | 11.9 M | |
| Total Stockholder Equity | 11.5 M | |
| Total Cashflows From Investing Activities | -156.6 K | |
| Property Plant And Equipment Net | 7.5 M | |
| Cash And Short Term Investments | 4.8 M | |
| Cash | 4.8 M | |
| Accounts Payable | 376.3 K | |
| Net Debt | -4.8 M | |
| 50 Day M A | 1.4556 | |
| Total Current Liabilities | 1.4 M | |
| Other Operating Expenses | 8.5 M | |
| Non Current Assets Total | 7.9 M | |
| Non Currrent Assets Other | 14.6 K | |
| Stock Based Compensation | 222.2 K |
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |